Michael Alper speaks at EuroMedTech 2014 on the trend of outward investment from China














Michael Alper from NeuvoMedica recently spoke on technology transfer and the trend of outward investment from China at EuroMedTech 2014 in Linz, Austria.

The Chinese medtech market is developing rapidly. New regulatory policies are making clear how foreign companies can operate effectively within the national market, and companies are looking at China as a viable next step in new market entry. But the traffic is not all going in one direction. Chinese companies are looking outside of the domestic market for small companies to support their growth within China and provide a presence internationally.

To see the recording on the recent panel follow the link:  http://www.partnering360.com/insight/showroom/id/506


On May 24, 2014, posted in: News by

Comments are closed.